At this juncture, genes such as AKT, PML, and PTEN appear to exist in a complex that interacts with IP3, and this cascade has demonstrated a particular intention, as AKT and PTEN are both members of the PI3K pathway, which is an extensively investigated signaling mechanism and is considered as a key player for cancer therapies [82]. The gene discussed is PTEN; the disease is cancer.